These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38667299)

  • 1. Microglia Mitigate Neuronal Activation in a Zebrafish Model of Dravet Syndrome.
    Brenet A; Somkhit J; Csaba Z; Ciura S; Kabashi E; Yanicostas C; Soussi-Yanicostas N
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
    Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
    PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective Excitatory/Inhibitory Synaptic Balance and Increased Neuron Apoptosis in a Zebrafish Model of Dravet Syndrome.
    Brenet A; Hassan-Abdi R; Somkhit J; Yanicostas C; Soussi-Yanicostas N
    Cells; 2019 Oct; 8(10):. PubMed ID: 31590334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
    Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
    PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral Comorbidities and Drug Treatments in a Zebrafish
    Grone BP; Qu T; Baraban SC
    eNeuro; 2017; 4(4):. PubMed ID: 28812061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a
    Zhou C; Satpute V; Yip KL; Anderson LL; Hawkins N; Kearney J; Arnold JC
    Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106836. PubMed ID: 38599513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Glycolysis and Mitochondrial Respiration in a Zebrafish Model of Dravet Syndrome.
    Kumar MG; Rowley S; Fulton R; Dinday MT; Baraban SC; Patel M
    eNeuro; 2016; 3(2):. PubMed ID: 27066534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Functional Differences between Duplicated Zebrafish Genes for Human
    Weuring WJ; Hoekman JW; Braun KPJ; Koeleman BPC
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome).
    Berio A; Piazzi A
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):95-8. PubMed ID: 25924876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing for Dravet syndrome in scn1Lab
    Sourbron J; Partoens M; Scheldeman C; Zhang Y; Lagae L; de Witte P
    Epilepsia; 2019 Feb; 60(2):e8-e13. PubMed ID: 30663052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility.
    Silvennoinen K; Gawel K; Tsortouktzidis D; Pitsch J; Alhusaini S; van Loo KMJ; Picardo R; Michalak Z; Pagni S; Martins Custodio H; Mills J; Whelan CD; de Zubicaray GI; McMahon KL; van der Ent W; Kirstein-Smardzewska KJ; Tiraboschi E; Mudge JM; Frankish A; Thom M; Wright MJ; Thompson PM; Schoch S; Becker AJ; Esguerra CV; Sisodiya SM
    Acta Neuropathol; 2022 Jul; 144(1):107-127. PubMed ID: 35551471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure-induced increase in microglial cell population in the developing zebrafish brain.
    Martins TG; Soliman R; Cordero-Maldonado ML; Donato C; Ameli C; Mombaerts L; Skupin A; Peri F; Crawford AD
    Epilepsy Res; 2023 Sep; 195():107203. PubMed ID: 37572541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia Remodelling and Neuroinflammation Parallel Neuronal Hyperactivation Following Acute Organophosphate Poisoning.
    Somkhit J; Yanicostas C; Soussi-Yanicostas N
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.
    Baraban SC; Dinday MT; Hortopan GA
    Nat Commun; 2013; 4():2410. PubMed ID: 24002024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
    Griffin A; Hamling KR; Knupp K; Hong S; Lee LP; Baraban SC
    Brain; 2017 Mar; 140(3):669-683. PubMed ID: 28073790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPRa-Mediated Upregulation of
    Weuring WJ; Dilevska I; Hoekman J; van de Vondervoort J; Koetsier M; van 't Slot RH; Braun KPJ; Koeleman BPC
    CRISPR J; 2021 Aug; 4(4):575-582. PubMed ID: 34406040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.
    Cha J; Filatov G; Smith SJ; Gammaitoni AR; Lothe A; Reeder T
    Epilepsia Open; 2024 Feb; 9(1):300-313. PubMed ID: 38018342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome.
    Liautard C; Scalmani P; Carriero G; de Curtis M; Franceschetti S; Mantegazza M
    Epilepsia; 2013 Jul; 54(7):1251-61. PubMed ID: 23663038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Na
    Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.